Bio-Techne

Health Care Life Sciences Tools & Services Minneapolis, Minnesota Last filing Aug 24, 2026 · FY2026

                    Revenue
                    FY2026
                
Not reported
                    
                    No matching line (4 accounts checked)
                    
                    Net income
                    FY2026
                
Not reported
                    
                    No matching line (4 accounts checked)
                    
                    Total assets
                    FY2026
                
$2.6B
                    
                    n/a
                    
                    Operating cash flow
                    FY2026
                
$292.1M
                    
                    n/a

18 yrs · FY2009–FY2026 5 filed · 1 derived · 3 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Balance Sheet

Assets, liabilities, and equity

28 accounts · 1 year

Total assets $2.6B

Total liabilities ~$478.5M

Shareholders equity $2.1B

Account	2026	Trend
Assets
Cash and Cash Equivalents	$264.7M
Accounts Receivable	$216.6M
Inventory	$195.7M
Other Current Assets	$67.4M
Total Current Assets	$744.4M
Property,Plant and Equipment	$231.8M
Operating Lease Assets	$67.3M
Goodwill	$975.4M
Intangible Assets	$303.5M
Other Noncurrent Assets	$264.3M
Total Assets	$2.6B
Liabilities
Accounts Payable	$26.7M
Accrued Liabilities	$82.0M
Deferred Revenue	$36.1M
Operating Lease Liabilities	$14.9M
Other Current Liabilities	$4.0M
Total Current Liabilities	$163.7M
Long Term Debt	$200.0M
Operating Lease Liabilities Noncurrent	$74.2M
Deferred Tax Liabilities	$19.3M
Other Noncurrent Liabilities	$21.3M
Equity
Common Stock	$1.6M
Additional Paid In Capital	$1.0B
Retained Earnings	$1.1B
Accumulated Other Comprehensive Income	$-70.6M
Other Equity	$0
Total Stockholders Equity	$2.1B
Total Liabilitiesand Equity	$2.6B

Income Statement

Revenue, expense, and profitability

4 accounts · 1 year

Revenue Not reported

Operating income Not reported

Net income Not reported

Account	2026	Trend
IncomeStatement
net Income Comprehensive Income	$171.2M
Earnings Per Share Basic Eps	$1
Earnings Per Share Diluted Eps	$1
Earnings Per Share Weighted Average Shares Diluted	$157.0M

Cash Flow Statement

Operating, investing, and financing flows

18 accounts · 1 year

Operating cash flow $292.1M

Investing cash flow $-18.2M

Financing cash flow $-169.1M

Account	2026	Trend
CashFlow
Operating Activities net Income	$181.9M
Operating Activities Depreciation and Amortization	$97.4M
Operating Activities Stock Based Compensation	$41.4M
Operating Activities Deferred Income Taxes	$13.2M
Operating Activities Changes In Operating Assets and Liabilities	$-41.3M
Operating Activities Other Non Cash Items	$-406.0K
Operating Activities net Cash From Operating Activities	$292.1M
Investing Activities Capital Expenditures	$-28.9M
Investing Activities Other Investing Activities	$10.7M
Investing Activities net Cash From Investing Activities	$-18.2M
Financing Activities Repayment of Debt	$-146.0M
Financing Activities Repurchase of Common Stock	$-41.7M
Financing Activities Dividends Paid	$-49.9M
Financing Activities Proceeds From Stock Issuance	$80.6M
Financing Activities Tax Withholding On Stock Based Compensation	$-12.1M
Financing Activities net Cash From Financing Activities	$-169.1M
Cash Reconciliation Effect of Exchange Rate On Cash	$-2.2M
Cash Reconciliation net Change In Cash	$102.5M

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2026
Profitability
Gross margin	—
Operating margin	—
Net margin	—
FCF margin	—
Growth
Revenue CAGR (3y)	—
Returns
ROE	—
ROA	—
ROIC	—
Liquidity
Current ratio	4.55x
Quick ratio	2.94x
Leverage
D/E	0.23x
Interest coverage	—
Efficiency
Asset turnover	—
Cash conversion cycle	—

Valuation

Price against fundamentals

FY2026 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Bio-Techne

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history